212 related articles for article (PubMed ID: 30760105)
1. Temporal Patterns of 14 Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio- SH i FT Study.
Bouwens E; Brankovic M; Mouthaan H; Baart S; Rizopoulos D; van Boven N; Caliskan K; Manintveld O; Germans T; van Ramshorst J; Umans V; Akkerhuis KM; Kardys I
J Am Heart Assoc; 2019 Feb; 8(4):e009555. PubMed ID: 30760105
[TBL] [Abstract][Full Text] [Related]
2. Cardiometabolic Biomarkers and Their Temporal Patterns Predict Poor Outcome in Chronic Heart Failure (Bio-SHiFT Study).
Brankovic M; Akkerhuis KM; Mouthaan H; Brugts JJ; Manintveld OC; van Ramshorst J; Germans T; Umans V; Boersma E; Kardys I
J Clin Endocrinol Metab; 2018 Nov; 103(11):3954-3964. PubMed ID: 30113647
[TBL] [Abstract][Full Text] [Related]
3. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I
Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure.
van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; de Boer RA; Asselbergs FW; Wajon EMCJ; Orsel JG; Boersma E; Hillege HL; Akkerhuis KM;
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187387
[TBL] [Abstract][Full Text] [Related]
5. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
van Boven N; Akkerhuis KM; Anroedh SS; Rizopoulos D; Pinto Y; Battes LC; Hillege HL; Caliskan KC; Germans T; Manintveld OC; Cornel JH; Constantinescu AA; Boersma E; Umans VA; Kardys I
Int J Cardiol; 2017 May; 235():124-132. PubMed ID: 28274577
[TBL] [Abstract][Full Text] [Related]
6. Utility of temporal profiles of new cardio-renal and pulmonary candidate biomarkers in chronic heart failure.
Brankovic M; Martijn Akkerhuis K; Mouthaan H; Constantinescu A; Caliskan K; van Ramshorst J; Germans T; Umans V; Kardys I
Int J Cardiol; 2019 Feb; 276():157-165. PubMed ID: 30098826
[TBL] [Abstract][Full Text] [Related]
7. Temporal evolution of liver function parameters predicts clinical outcome in chronic heart failure patients (Bio-SHiFT study).
Klimczak-Tomaniak D; Andrzejczyk K; Abou Kamar S; Baart S; van Boven N; Akkerhuis KM; Constantinescu A; Caliskan K; Simsek S; Germanse T; van Ramshorst J; Brugts J; Kuch M; Umans V; Boersma E; Kardys I
Cardiol J; 2024; 31(3):409-417. PubMed ID: 38408202
[TBL] [Abstract][Full Text] [Related]
8. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failure.
Lala RI; Lungeanu D; Darabantiu D; Pilat L; Puschita M
Herz; 2018 Mar; 43(2):146-155. PubMed ID: 28235980
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of serial high-sensitivity troponin I measurements following acute cardiac decompensation-correlation with longer-term clinical outcomes and reverse remodelling.
Wallenborn J; Marx A; Störk S; Güder G; Brenner S; Ertl G; Angermann CE
Int J Cardiol; 2017 Apr; 232():199-207. PubMed ID: 28094131
[TBL] [Abstract][Full Text] [Related]
11. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific temporal evolution of circulating biomarkers in patients with chronic heart failure with reduced ejection fraction.
Schreuder MM; Schuurman A; Akkerhuis KM; Constantinescu AA; Caliskan K; van Ramshorst J; Germans T; Umans VA; Boersma E; Roeters van Lennep JE; Kardys I
Int J Cardiol; 2021 Jul; 334():126-134. PubMed ID: 33940096
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
[TBL] [Abstract][Full Text] [Related]
14. Associations of serially measured PCSK9, LDLR and MPO with clinical outcomes in heart failure.
Bouwens E; Schuurman AS; Akkerhuis KM; Manintveld OC; Caliskan K; van Ramshorst J; Germans T; Umans VA; Boersma E; Kardys I
Biomark Med; 2021 Mar; 15(4):247-255. PubMed ID: 33590771
[No Abstract] [Full Text] [Related]
15. Circulating Biomarkers of Cell Adhesion Predict Clinical Outcome in Patients with Chronic Heart Failure.
Bouwens E; van den Berg VJ; Akkerhuis KM; Baart SJ; Caliskan K; Brugts JJ; Mouthaan H; Ramshorst JV; Germans T; Umans VAWM; Boersma E; Kardys I
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936828
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; Orsel JG; Westenbrink BD; Brunner-la Rocca HP; van Miltenburg AJM; Boersma E; Hillege HL; Akkerhuis KM;
J Am Coll Cardiol; 2017 Nov; 70(19):2378-2388. PubMed ID: 29096809
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
[TBL] [Abstract][Full Text] [Related]
18. Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study).
Brankovic M; Akkerhuis KM; Hoorn EJ; van Boven N; van den Berge JC; Constantinescu A; Brugts J; van Ramshorst J; Germans T; Hillege H; Boersma E; Umans V; Kardys I
Clin Cardiol; 2020 Jun; 43(6):630-638. PubMed ID: 32298007
[TBL] [Abstract][Full Text] [Related]
19. Repeated Echocardiograms Do Not Provide Incremental Prognostic Value to Single Echocardiographic Assessment in Minimally Symptomatic Patients with Chronic Heart Failure: Results of the Bio-SHiFT Study.
van den Berg VJ; Strachinaru M; Akkerhuis KM; Baart S; Brankovic M; Constantinescu AA; Cornel JH; Manintveld OC; Umans VAWM; Rizopoulos D; Geleijnse ML; Boersma E; van Dalen BM; Kardys I
J Am Soc Echocardiogr; 2019 Aug; 32(8):1000-1009. PubMed ID: 31230778
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
Felker GM; Fiuzat M; Shaw LK; Clare R; Whellan DJ; Bettari L; Shirolkar SC; Donahue M; Kitzman DW; Zannad F; Piña IL; O'Connor CM
Circ Heart Fail; 2012 Jan; 5(1):72-8. PubMed ID: 22016505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
